Residual Vascular Risk in Diabetes - Will the SPPARM Alpha Concept Hold the Key?
Overview
Affiliations
The dawn of a new era of targeted lipid-lowering therapies.
Tokgozoglu L, Libby P Eur Heart J. 2022; 43(34):3198-3208.
PMID: 35051271 PMC: 9448630. DOI: 10.1093/eurheartj/ehab841.
Jin J, Zhang H, Cao Y, Liu H, Hua Q, Li Y Cardiovasc Diabetol. 2020; 19(1):152.
PMID: 32981521 PMC: 7520976. DOI: 10.1186/s12933-020-01125-1.
Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic Acid.
Mason R, Libby P, Bhatt D Arterioscler Thromb Vasc Biol. 2020; 40(5):1135-1147.
PMID: 32212849 PMC: 7176343. DOI: 10.1161/ATVBAHA.119.313286.